News and Blog

Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator

News & Events

Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator

Seminar Title: ” Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator”

Please go to: http://news.uoc.gr/news/2022/08-04/PapamathaiakisAnnouncement_Research_Seminar.pdf 

Joint Seminar Series in Translational and Clinical Medicine: UoC Medical School – IMBB-FORTH – UCRC  Wednesday, April 13, 15:00 – 16:00 local time

  “Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator”

  Sifis Papamathaiakis, Emeritus Professor, Department of Biology, UoC & Affiliated Researcher of IMBB-FORTH

  Platform link  https://zoom.us/j/95222166701